Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn’t make sense, former officials said. Previous article: Collaborative Networks Become Popular Lifeline for Rural Hospitals Prev Next article: Watch: Why Is Having a Baby So Expensive in the US? Next
